Oncohema Key

Characteristic TheraSphere® SIR-Sphere® Isotope 90Y 90Y Half-Life (h) 64.2 64.2 Particle Size (μm) 20–30 20–60 Range of spheres per vial 1.2–8.0 million 40–80 million Activity per sphere (Bq) 2500 50…

Stage AJCC- clinical staging AJCC-staging I 81 (51 %) 60 (38 %) II 57 (36 %) 49 (31 %) III 7 (4 %) 9 (6 %) IV 0 1 (0.6 %) No lesions 14 (9 %) 12 (7 %)…

Fig. 1 Treatment algorithm of patients with HCC based on serum bilirubin level and indocyanine green retention rate at 15 min. Adapted from Makuuchi et al. [8] 2.3 Assessment of the Future…

Chemical ablation    – Ethanol injection   Thermal ablation    – Radiofrequency ablation  – Microwave ablation  – Laser ablation  – Cryoablation   Irreversible electroporation   2 Chemical Ablation The seminal…

Fig. 1 Macroscopic aspects of Hepatocellular carcinoma: a Nodular pattern of HCC developed in a cirrhotic liver. b Infiltrative pattern of HCC developed in a cirrhotic liver. c Early HCC (progressed…

Fig. 1 Cell signalling pathways implicated in hepatocarcinogenesis Overexpression of HGF and c-MET occurs in 33 and 20–48 % of human HCC tumors, respectively [41–45] and appears to be associated with earlier…

Fig. 1 a Segment VII hepatocellular carcinoma during arterial phase of computed tomography showing a hypervascular tumour before TACE. b Computed tomography image 2 years after TACE. Compact uptake of lipiodol in…

Fig. 1 Histologic features of fibrolamellar carcinoma. Hematoxylin-eosin stained photomicrograph demonstrates large hepatocellular tumor cells with eosinophilic cytoplasm and prominent nucleoli embedded in a lamellar, fibrous stroma 3 Presentation and Laboratory…

Fig. 1 Algorithm for the surveillance of hepatocellular carcinoma (HCC) (cited from the Group formed to establish the Guidelines for Evidence-Based Clinical Practice for the Treatment of Liver Cancer [89], with…